Retransplantation of patients with severe posttransplant hepatitis B in the first allograft

Transplantation

Volumn 64, Issue 3, 1997, Pages 410-414

  Ishitani, M ^a,d   McGory, R ^a   Dickson, R ^b   Caldwell, S ^a   Bickston, S ^a   McCullough, C ^a   Pruett, T ^a   Terrault, N ^c   Roberts, J ^c   Ascher, N ^c   Wright, T ^c   Lake, J ^c  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLOGRAFT; ARTICLE; CLINICAL ARTICLE; HEPATITIS B; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER TRANSPLANTATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RECURRENT INFECTION; REOPERATION;

ADULT; ARGININE; DNA, VIRAL; GLYCINE; GRAFT REJECTION; GRAFT SURVIVAL; HEPATITIS ANTIBODIES; HEPATITIS B; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOBLOTTING; IMMUNOGLOBULINS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POINT MUTATION; REOPERATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 18144436479     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199708150-00006     Document Type: Article

References (27)

1. Schiff ER. Liver transplantation for hepatitis B [Editorial]. Liver Transplant Surg 1995; 1(4): 259.
2. Lake JR. Should liver transplantation be performed for patients with chronic hepatitis B? Yes! Liver Transplant Surg 1995; 1(4): 260.
3. Wiesner RH, Krom RAF. Liver transplantation for hepatitis B: the con aspect. Liver Transplant Surg 1995; 1(4): 265.
4. Starzl TE, Demetris AJ, Thiel DV. Liver transplantation. N Engl J Med 1989; 321(16): 1092.
5. Todo S, Demetris AJ, Thiel DV, Teperman L, Fung JJ, Starzl TE. Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology 1991; 14(4): 619.
6. O'Grady JG, Williams R. Liver transplantation for viral hepatitis. Br Med Bull 1990; 45(2): 480.
7. Samuel D, Muller R, Alexander G, et al. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 1993; 329(25): 1842.
8. König V, Hopf U, Neuhaus P, et al. Long-term follow-up of hepatitis B virus-infected recipients after orthotopic liver transplantation. Transplantation 1994; 58(5): 553.
9. Bodenheimer HC Jr, Schulger LK, Sheiner P. Viral hepatitis in liver transplant recipients. Clin Transplant 1995; 9: 211.
10. Crippin J, Foster B, Carlen S, Borcich A, Bodenheimer H Jr. Retransplantation in hepatitis B: a multicenter experience. Transplantation 1994; 57(6): 823.
11. Roche B, Samuel D, Gigou M, et al. Apparent de novo hepatitis B virus infection after liver transplantation. J Hepatol 1996; 26(3): 517.
12. McGory RW, Ishitani MB, Oliveira WM, et al. Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization. Transplantation 1996; 61(9): 1358.
13. Ishitani M, McGory R, Kiyasu P, Caldwell S, Lobo P, Stevenson W, Pruett T. Six-month versus continued intermittent HBIg administration in the prevention of hepatitis B reinfection after liver transplantation [Abstract]. Gastroenterology 1993; 104(4): A902.
14. McGory R, Ishitani M, Oliveira W, et al. Pharmacokinetics of hepatitis B immune globulin in patients with orthotopic liver transplant secondary to chronic hepatitis B virus-induced cirrhosis [Abstract]. Hepatology 1994; 20(4): 130A.
15. Kiyasu P, Ishitani M, McGory R, et al. Prevention of hepatitis B "rerecurrence" after a second liver transplant: the role of maintenance polyclonal HBIG therapy. Transplantation 1994; 58: 954.
16. Terrault N, Zhou S, Combs C, et al. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin. Hepatology 1996; 24: 1327.
17. Chazouilleres O, Mamish D, Kim M, et al. "Occult" hepatitis B virus as source of infection in liver transplant recipients. Lancet 1994; 343: 142.
18. Hsu SM, Raine L, Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981; 29(4): 577.
19. Terrault, N, Zhou S, Singleton S, et al. Mutational analysis of surface (S) and polymerase (P) genes in liver transplant (OLT) recipients failing HBIG immunoprophylaxis [Abstract]. Hepatology 1996; 24(4): 181A.
20. Carman W, Trautwein C, van Deursen F, et al. Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis. Hepatology 1996; 24: 489.
21. McMahon G, Ehrlich P, Moustafa Z, et al. Genetic alterations in the gene encoding the major HbsAg: DNA and immunological analysis of recurrent HBsAg derived from monoclonal antibody-treated liver transplant patients. Hepatology 1992; 15: 757.
22. Dienstag J, Perrillo R, Schiff E, Bartholomew M, Vicary C, Rubin M. A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 1995; 333(25): 1657.
23. Honkoop P, de Man RA, Heijtink RA, Schaim SW. Hepatitis B reactivation after lamivudine. Lancet 1995; 346: 1156.
24. Ling R, Mutimer D, Ahmed M, et al. Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine. Hepatology 1996; 24(3): 711.
25. Boker K, Ringe B, Kruger M, Pichlmayr R, Manns P: Prostaglandin E plus famciclovir: a new concept for the treatment of severe hepatitis B after liver transplantation. Transplantation 1994; 57(12): 1706.
26. Gish R, Lau J, Brooks L, et al. Ganciclovir treatment of hepatitis B virus infection in liver transplant recipients. Hepatology 1996; 23(1): 1.
27. Singh N, Gayowski T. Lack of sustained efficacy of combination ganciclovir and foscarnet for hepatitis B virus recurrence after liver transplantation. Transplantation 1995; 59(11): 1629.